The True Potential Could Be Right Around The Corner
During the period January 2018 – the present we have been watching the price, news and corporate developments at (GTBP).The company has added an ALL-STAR management roster, increased the strength of its board and received positive results on clinical trials. GT Biopharma (GTBP) has also begun to align itself with a “Major Pharma” company & that could present even more potential ahead.
Click Here To Read The Rest Of The Story!
Canada’s Legalization Could Mean Big THings For One MJ Stock
A financial boom not seen since the dot-com mania of the late 1990s has taken over Canada. The legalization of recreational marijuana, scheduled for this fall, is not only a momentous social event, but also a rare opportunity for to be in on the birth of what they hope will become a multibillion-dollar industry. One Company Has Put Its Wheels In Motion & That Could Mean Big Potential Ahead
Click Here For More Information
Marijuana Prohibition is Ending & Opportunity is Beginning
It seems inevitable that we are destined to see the fall of Marijuana Prohibition within the United States and soon. Medical Marijuana is now legal in 30 out of 50 states & recreationally legal in 9 out of those 30 Unites States of America. Marijuana and the rise of the legal Cannabis industry appears to be taking over with very little in its way.
More Details Here
Marijuana Stocks: What Do Parents and Cannabis Producers Have in Common?
While some might describe the time before the market launch as the “calm before the storm,” it has been anything but that for licensed cannabis distributors around the country. They have been in a merger and acquisition frenzy to prepare for what is expected to be the most successful economically stimulating event to hit Canada since the early 1990s.
Click Here For More Information
Disclaimer: Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and GT Biopharma, Midam has been paid $200,000 from the company and ZERO shares of GT Biopharma Inc. for a duration beginning July 16, 2018 and ending August 16, 2018. Midam Ventures has been paid an additional $200k by GT Biopharma and has extended its marketing period through Sept 16, 2018. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
